Who invested in Immune-Onc Therapy?
Immune-Onc Therapy's investors include CLI Ventures et al and Fame Mount Limited.
United States · Series A startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Immune-Onc Therapy and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$7.0Mraised across 1 round since 2016, from 1 source
Immune-Onc Therapy's investors include CLI Ventures et al and Fame Mount Limited.
Immune-Onc Therapy has raised $7.0M across 1 round since 2016.
Immune-Onc Therapy's most recent round was a Series A of $7.0M in Sept 2016.
Its most recent round, $7.0M in Sept 2016, is also its largest on record.
Immune-Onc Therapy's first round on record, in Sept 2016, was backed by CLI Ventures et al and Fame Mount Limited.
Immune-Onc Therapy's latest named round is a Series A, in Sept 2016.
Immune-Onc Therapy is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.